| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Dec 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Dec 03, 2015, 06:53 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Dec 01, 2015 | Sale | $76.31 | 9,000 | 686,819 | 9,983 | Dec 03, 2015, 06:53 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Nov 27, 2015 | Option/RSU Exercise | $1.35 | 15,000 | 20,250 | 90,507 | Nov 30, 2015, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Nov 27, 2015 | Sale | $86.45 | 15,000 | 1,296,680 | 78,107 | Nov 30, 2015, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Nov 16, 2015 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Nov 18, 2015, 07:32 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Nov 16, 2015 | Sale | $78.16 | 6,145 | 480,270 | 7,343 | Nov 18, 2015, 07:32 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Nov 16, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Nov 18, 2015, 07:31 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Nov 16, 2015 | Sale | $78.08 | 9,000 | 702,681 | 13,930 | Nov 18, 2015, 07:31 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Nov 16, 2015 | Sale | $78.13 | 9,567 | 747,507 | 11,084 | Nov 18, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Nov 16, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Nov 18, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Nov 10, 2015 | Option/RSU Exercise | $1.35 | 5,000 | 6,750 | 80,507 | Nov 12, 2015, 06:33 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Nov 10, 2015 | Sale | $80.00 | 5,000 | 400,000 | 75,507 | Nov 12, 2015, 06:33 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Nov 10, 2015 | Option/RSU Exercise | $6.89 | 30,800 | 212,212 | 37,704 | Nov 12, 2015, 06:32 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Nov 10, 2015 | Sale | $80.02 | 30,800 | 2,464,616 | 6,904 | Nov 12, 2015, 06:32 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Nov 02, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Nov 04, 2015, 07:06 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Nov 02, 2015 | Sale | $71.07 | 9,000 | 639,652 | 10,298 | Nov 04, 2015, 07:06 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Nov 02, 2015 | Option/RSU Exercise | $6.89 | 7,700 | 53,053 | 14,604 | Nov 04, 2015, 07:05 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Nov 02, 2015 | Sale | $71.08 | 7,700 | 547,292 | 14,127 | Nov 04, 2015, 07:05 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Oct 27, 2015 | Sale | $69.91 | 10,000 | 699,120 | 80,407 | Oct 28, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Oct 27, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Oct 28, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Oct 15, 2015 | Sale | $62.58 | 9,567 | 598,731 | 12,113 | Oct 19, 2015, 07:30 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Oct 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Oct 19, 2015, 07:30 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Oct 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Oct 19, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Oct 15, 2015 | Sale | $62.59 | 9,000 | 563,319 | 14,891 | Oct 19, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Oct 15, 2015 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Oct 19, 2015, 07:28 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Oct 15, 2015 | Sale | $62.57 | 6,145 | 384,509 | 7,982 | Oct 19, 2015, 07:28 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Oct 01, 2015 | Option/RSU Exercise | $6.89 | 7,700 | 53,053 | 14,604 | Oct 02, 2015, 07:19 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Oct 01, 2015 | Sale | $55.11 | 7,700 | 424,347 | 6,904 | Oct 02, 2015, 07:19 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Oct 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Oct 02, 2015, 07:18 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Oct 01, 2015 | Sale | $54.81 | 9,000 | 493,326 | 9,758 | Oct 02, 2015, 07:18 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Sep 28, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Sep 30, 2015, 07:01 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Sep 28, 2015 | Sale | $55.87 | 10,000 | 558,672 | 82,707 | Sep 30, 2015, 07:01 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Sep 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Sep 17, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Sep 15, 2015 | Sale | $64.34 | 9,000 | 579,018 | 10,782 | Sep 17, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Sep 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Sep 17, 2015, 08:00 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Sep 15, 2015 | Sale | $64.36 | 9,567 | 615,733 | 8,234 | Sep 17, 2015, 08:00 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Sep 15, 2015 | Sale | $64.33 | 6,145 | 395,320 | 5,379 | Sep 17, 2015, 07:59 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Sep 15, 2015 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Sep 17, 2015, 07:59 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 03, 2015 | Option/RSU Exercise | $6.89 | 316 | 2,177 | 7,220 | Sep 08, 2015, 07:14 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 03, 2015 | Sale | $55.00 | 316 | 17,380 | 6,904 | Sep 08, 2015, 07:14 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 08, 2015 | Option/RSU Exercise | $6.89 | 7,384 | 50,876 | 14,288 | Sep 08, 2015, 07:14 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 08, 2015 | Sale | $55.00 | 7,384 | 406,120 | 6,904 | Sep 08, 2015, 07:14 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Sep 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Sep 03, 2015, 07:07 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Sep 01, 2015 | Sale | $51.81 | 9,000 | 466,292 | 5,869 | Sep 03, 2015, 07:07 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Aug 27, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Aug 28, 2015, 07:07 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Aug 27, 2015 | Sale | $53.62 | 10,000 | 536,156 | 83,407 | Aug 28, 2015, 07:07 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Aug 17, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Aug 19, 2015, 08:04 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Aug 17, 2015 | Sale | $60.87 | 9,000 | 547,820 | 10,807 | Aug 19, 2015, 08:04 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Aug 17, 2015 | Sale | $60.88 | 9,567 | 582,407 | 8,482 | Aug 19, 2015, 08:03 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Aug 17, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Aug 19, 2015, 08:03 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Aug 17, 2015 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 7,144 | Aug 19, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Aug 17, 2015 | Sale | $60.90 | 6,145 | 374,236 | 5,588 | Aug 19, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Aug 03, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Aug 04, 2015, 07:30 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Aug 03, 2015 | Sale | $72.14 | 9,000 | 649,246 | 6,348 | Aug 04, 2015, 07:30 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Aug 03, 2015 | Sale | $72.11 | 7,700 | 555,242 | 10,800 | Aug 04, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Aug 03, 2015 | Option/RSU Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Aug 04, 2015, 07:29 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jul 27, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 84,566 | Jul 28, 2015, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jul 27, 2015 | Sale | $68.48 | 10,000 | 684,818 | 78,804 | Jul 28, 2015, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jul 15, 2015 | Option/RSU Exercise | $10.66 | 22,167 | 236,251 | 23,166 | Jul 23, 2015, 02:29 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jul 15, 2015 | Sale | $71.89 | 22,167 | 1,593,674 | 21,735 | Jul 23, 2015, 02:29 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Jul 15, 2015 | Sale | $71.92 | 9,000 | 647,257 | 13,812 | Jul 20, 2015, 09:03 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Jul 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Jul 20, 2015, 09:03 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jul 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Jul 20, 2015, 09:02 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jul 15, 2015 | Sale | $71.90 | 9,567 | 687,828 | 10,296 | Jul 20, 2015, 09:02 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jul 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Jul 02, 2015, 08:36 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jul 01, 2015 | Sale | $61.90 | 9,000 | 557,075 | 6,708 | Jul 02, 2015, 08:36 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Jul 01, 2015 | Sale | $61.92 | 7,700 | 476,781 | 10,306 | Jul 02, 2015, 08:35 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Jul 01, 2015 | Option/RSU Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Jul 02, 2015, 08:35 PM | |
| KITE | Kite Pharma, Inc. | Farah Champsi | Director | Jun 30, 2015 | Sale | $62.35 | 664,102 | 41,403,802 | 2,234,261 | Jul 02, 2015, 07:44 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jun 29, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 84,566 | Jul 01, 2015, 07:15 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jun 29, 2015 | Sale | $59.65 | 10,000 | 596,542 | 80,766 | Jul 01, 2015, 07:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Jun 15, 2015 | Sale | $57.00 | 9,000 | 513,031 | 11,608 | Jun 17, 2015, 07:19 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Jun 25, 2014 | Buy | $17.00 | 4,000 | 68,000 | 5,218 | Jun 17, 2015, 07:19 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | Jun 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Jun 17, 2015, 07:19 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Jun 25, 2014 | Buy | $17.00 | 4,000 | 68,000 | 6,000 | Jun 17, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Jun 15, 2015 | Option/RSU Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Jun 17, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Jun 15, 2015 | Sale | $56.98 | 7,700 | 438,749 | 11,267 | Jun 17, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jun 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Jun 17, 2015, 07:16 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jun 15, 2015 | Sale | $56.98 | 9,567 | 545,168 | 8,371 | Jun 17, 2015, 07:16 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jun 15, 2015 | Option/RSU Exercise | $0.70 | 8,625 | 6,037 | 9,624 | Jun 17, 2015, 07:15 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jun 15, 2015 | Sale | $56.99 | 8,625 | 491,497 | 7,047 | Jun 17, 2015, 07:15 PM | |
| KITE | Kite Pharma, Inc. | Ran Nussbaum | Director | Jun 01, 2015 | Sale | $55.34 | 80,760 | 4,469,230 | 236,228 | Jun 03, 2015, 07:40 PM | |
| KITE | Kite Pharma, Inc. | Ran Nussbaum | Director | Jun 02, 2015 | Sale | $55.36 | 224,674 | 12,437,229 | 24,070 | Jun 03, 2015, 07:40 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jun 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Jun 03, 2015, 07:38 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jun 01, 2015 | Sale | $54.60 | 9,000 | 491,421 | 5,766 | Jun 03, 2015, 07:38 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | May 27, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 84,566 | May 29, 2015, 06:56 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | May 27, 2015 | Sale | $50.59 | 10,000 | 505,934 | 74,766 | May 29, 2015, 06:56 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | May 15, 2015 | Sale | $50.17 | 8,625 | 432,709 | 5,133 | May 19, 2015, 08:02 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | May 15, 2015 | Option/RSU Exercise | $0.70 | 8,625 | 6,037 | 9,624 | May 19, 2015, 08:02 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | May 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 10,218 | May 19, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | VP Clinical Development | May 15, 2015 | Sale | $50.15 | 9,000 | 451,339 | 5,512 | May 19, 2015, 08:01 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | May 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 11,262 | May 19, 2015, 08:00 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | May 15, 2015 | Sale | $50.16 | 9,567 | 479,867 | 6,076 | May 19, 2015, 08:00 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | May 01, 2015 | Sale | $50.72 | 9,000 | 456,451 | 5,861 | May 05, 2015, 08:28 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | May 01, 2015 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 10,017 | May 05, 2015, 08:28 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Apr 27, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 74,566 | Apr 29, 2015, 09:54 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Apr 27, 2015 | Sale | $59.76 | 10,000 | 597,624 | 64,566 | Apr 29, 2015, 05:48 PM | |
| KITE | Kite Pharma, Inc. | Ran Nussbaum | Director | Mar 27, 2015 | Sale | $61.24 | 77,873 | 4,769,020 | 216,064 | Mar 31, 2015, 08:38 PM | |
| KITE | Kite Pharma, Inc. | Ran Nussbaum | Director | Mar 30, 2015 | Sale | $59.91 | 115,857 | 6,941,468 | 149,116 | Mar 31, 2015, 08:38 PM | |
| KITE | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | Jun 25, 2014 | Conversion | - | 1,529,565 | - | 2,275,472 | Aug 01, 2014, 02:10 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More